Inventor · disambiguated record
Jurg Sommer
Also filed as: SOMMER JUERG M · SOMMER JURG · SOMMER JURG M
14 granted patents·5 pending applications·148 citations·filing 2005–2024
93Inventor score
Files withBIOVERATIV THERAPEUTICS INC9BIOGEN HEMOPHILIA INC2DUMONT JENNIFER A2GENZYME CORP2BANKIEWICZ KRZYSZTOF1
Top patents by PatentIndex Score
19 records- 0194US11266720B2Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·6 cites·64 claims
- 0293US10881742B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·5 cites·26 claims
- 0393US9050318B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2010·Granted Jun 9, 2015·28 cites·31 claims
- 0492US7749490B2Mutant IL-10UNIV COLORADO·Filed 2006·Granted Jul 6, 2010·34 cites·4 claims
- 0590US9241978B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofBIOGEN HEMOPHILIA INC·Filed 2013·Granted Jan 26, 2016·15 cites·21 claims
- 0689US10001495B2Blood factor monitoring assay and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Jun 19, 2018·6 cites·22 claims
- 0788US12186375B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·19 claims
- 0886US2025195620A1Factor viii chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0984US10010622B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2012·Granted Jul 3, 2018·7 cites·22 claims
- 1081US11372008B2Blood factor monitoring assay and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Jun 28, 2022·1 cites·9 claims
- 1181US7815623B2Stepped cannulaGENZYME CORP·Filed 2005·Granted Oct 19, 2010·28 cites·30 claims
- 1277US2022265780A1Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1375US8337458B2Stepped cannulaBANKIEWICZ KRZYSZTOF·Filed 2010·Granted Dec 25, 2012·11 cites·15 claims
- 1474US2022412996A1Blood factor monitoring assay and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1568US10656167B2Assays to monitor bleeding disordersSOMMER JURG·Filed 2012·Granted May 19, 2020·2 cites·13 claims
- 1668US9302070B2Stepped cannulaGENZYME CORP A SANOFI COMPANY·Filed 2012·Granted Apr 5, 2016·4 cites·16 claims
- 1767US11747351B2Assays to monitor bleeding disordersBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·0 cites·15 claims
- 1854US2016199455A1Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use ThereofBIOGEN HEMOPHILIA INC·Filed 2015·Application pending·0 cites
- 1954US2016296694A1Stepped cannulaGENZYME CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jurg Sommer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →